ClinicalTrials.gg
CompletedNCT07891559TSTVUpdated Oct 23, 2026

Trauma Suppression Training for Veterans

An interventional study of Web-based Think/No-Think retrieval-suppression training in Posttraumatic Stress Disorder (PTSD), sponsored by Palo Alto Veterans Institute for Research. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-23.

Sponsored by Palo Alto Veterans Institute for Research · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 11 months after the study started (first participant enrolled Nov 2025, registered Oct 2026).
Updated Oct 23, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
11
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

Intrusive memories of trauma are a core and often persistent symptom of posttraumatic stress disorder (PTSD). This study tested whether veterans with PTSD could take part in a computer-based training program that teaches people to stop unwanted memories from coming to mind (the Think/No-Think procedure). Veterans listed personally significant negative and positive events, learned a cue word for each, and then practiced suppressing the negative events and vividly recalling the positive ones over three consecutive days, in person or remotely. The study measured whether veterans could be recruited and retained, whether they completed the training, how acceptable they found it, and whether it was safe. It also explored changes in anxiety, worry, mood, wellbeing, and depressive symptoms, and in how vivid and distressing the trained memories were.

Read the detailed description

This single-site feasibility study adapted a web-based Think/No-Think retrieval-suppression training program, previously tested in the general population, for veterans with PTSD. At an introductory session, participants gave consent, completed baseline questionnaires, and received instructions for generating 40 personally significant events (20 negative, 20 positive), each with a cue (Hint) word and a key-detail (Response) word. After stimulus preparation (1 to 3 days), participants completed three consecutive training days. On Day 1 they rated each event and learned the 40 cue-detail pairs. On each training day they completed four runs of the Training Task: on No-Think trials (negative events) they recognized the event but stopped it from coming to mind without substituting other thoughts; on Think trials (positive events) they recalled the event and imagined it vividly. Untrained events of each valence served as baseline items. On Day 3 participants completed a cued-recall test, re-rated event vividness and affect, and completed post-training questionnaires.

The protocol was revised during the study through IRB-approved amendments. Initially, participants were randomly assigned to one of four instruction conditions that differed only in the suppression strategy offered (flexible strategy, visual focus, breath focus, or heart-centered visualization), and sessions were held in person. From December 2025, all sessions could be held remotely and all participants received the flexible-strategy instruction, with the structured strategies suggested as optional aids. From February 2026, positive and negative events could be drawn from the past, present, or future rather than only past negative and future positive events.

02

Conditions studied

  • Posttraumatic Stress Disorder (PTSD)

Keywords

  • intrusive memories
  • thought suppression
  • retrieval suppression
  • Think/No-Think
  • memory control
  • veterans
  • feasibility
  • web-based intervention
  • inhibitory control
  • cognitive training
03

In context

Stress Disorders, Post-Traumatic

2,284 studies on the registry are indexed under Stress Disorders, Post-Traumatic; 557 are open to participants now.

This study's enrollment of 11 is below the median of 70 across 1,897 interventional studies indexed under Stress Disorders, Post-Traumatic.

Browse Stress Disorders, Post-Traumatic studies →

Lead sponsor

Palo Alto Veterans Institute for Research is the lead sponsor of 52 studies on the registry; 9 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18 years or older.
  • Veteran who served in active combat or in a combat zone.
  • Current PTSD, defined by a PTSD Checklist for DSM-5 (PCL-5) score above 38 at screening or a self-reported prior PTSD diagnosis

Exclusion criteria

Exclusion Criteria:

  • Participation in another concurrent clinical trial.
  • Past participation in a research study involving the Think/No-Think task.
  • No access to a laptop computer for all training days, or no experience using Microsoft Excel or Google Sheets.
  • Color blindness; dyslexia or other reading disability; inability to read and communicate in English.
  • History of psychotic episodes; neurodegenerative disorder (e.g., dementia, Parkinson's disease).
  • Current or recent (within 60 days) suicidal or homicidal intent at screening.
  • Schizophrenia, bipolar I disorder, or psychosis for any reason within the prior six months.
  • Substance dependence (other than nicotine) within the prior 30 days.
  • Poorly controlled seizure disorder.
  • Psychotropic medication started within 8 weeks before screening.
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
11 participants (actual)

Study arms

  • Experimental
    Think/No-Think suppression training

    Participants generate 40 personally significant events, learn cue-detail word pairs, and complete three consecutive days of web-based Think/No-Think training (No-Think trials for negative events, Think trials for positive events).

    Behavioral: Web-based Think/No-Think retrieval-suppression training

Interventions

  • BehavioralWeb-based Think/No-Think retrieval-suppression training

    Each training day comprises four runs in which 16 trained events (8 Think, 8 No-Think) are each presented three times (192 trials per day); each cue is shown for 5 seconds. On No-Think trials, participants keep their attention on the cue while preventing the associated memory from coming to mind, without substituting other thoughts.

06

What researchers measure

Primary outcomes

  1. Recruitment

    Number of eligible veterans enrolled (consented) during the recruitment period, against the target of 20 completers.

    Time frame: Recruitment period (November 2025 to July 2026)

  2. Retention

    Percentage of consented participants who complete all study sessions.

    Time frame: From consent through Training Day 3 (about 5 days)

  3. Protocol adherence

    Percentage of participants who begin training and complete all three training days.

    Time frame: Training Days 1 to 3

  4. Number of participants rating the suppression strategy as useful outside the laboratory

    Single post-training yes/no item: "Do you think that the suppression strategy you learned through the course of this training is useful or helpful to use outside the lab in your own life?" Reported as the number and percentage of participants answering Yes; a higher percentage indicates greater acceptability.

    Time frame: End of Training Day 3

  5. Number of completers whose training was delivered on the protocol-specified schedule

    Delivery was recorded as per protocol when stimulus preparation was followed by three training days on consecutive days, as specified in the protocol. Reported as the number and percentage of completers; a higher percentage indicates greater fidelity of delivery.

    Time frame: From stimulus preparation through Training Day 3 (about 5 days)

  6. Adverse events

    Number of participants with serious adverse events.

    Time frame: From consent through Training Day 3

  7. Number of participants likely to re-use the suppression strategy, assessed by a 5-point rating item

    Single post-training item: "How likely are you to re-use the suppression strategy you learned to decrease your anxiety or thoughts about the negative events in your life?" Rated from 1 (Very unlikely) to 5 (Very likely); minimum 1, maximum 5; higher scores indicate greater likelihood of re-use (a better outcome). Reported as the number and percentage of participants rating Likely (4) or Very likely (5).

    Time frame: End of Training Day 3

  8. Self-rated effectiveness at stopping thoughts about upsetting events, assessed by a 5-point rating item

    Participants rated how effectively they could stop thoughts about their upsetting events at the beginning of training (Training Day 1, rated retrospectively) and at the end of training (Training Day 3). Each rating ranges from 1 (Not at all effective) to 5 (Extremely effective); higher scores indicate better self-rated effectiveness (a better outcome).

    Time frame: End of Training Day 3

  9. Number of completers confirming the suppression-strategy instruction they were assigned, assessed by a post-training yes/no item

    After training, participants were shown the strategy instruction for their assigned condition and asked to confirm (Yes/No) that it was the strategy they had practiced. Reported as the number and percentage answering Yes; a higher percentage indicates more accurate delivery of the assigned instruction.

    Time frame: Training Day 3

Secondary outcomes

  1. Warwick-Edinburgh Mental Well-being Scale (WEMWBS)

    Change in total score (range 14 to 70; higher scores indicate better well-being).

    Time frame: Baseline (introductory session) and end of Training Day 3 (about 5 days)

  2. Positive and Negative Affect Schedule (PANAS)

    Change in positive affect and negative affect subscale scores (10 items each, rated 1 to 5; each subscale range 10 to 50). Higher positive-affect scores indicate a better outcome; higher negative-affect scores indicate a worse outcome.

    Time frame: Baseline (introductory session) and end of Training Day 3 (about 5 days)

  3. State-Trait Anxiety Inventory, state form (STAI-S)

    Change in total score (range 20 to 80; higher scores indicate more anxiety).

    Time frame: Baseline (introductory session) and end of Training Day 3 (about 5 days)

  4. Penn State Worry Questionnaire-Past Day (PSWQ-PD)

    Change in total score (range 0 to 60; higher scores indicate more worry).

    Time frame: Baseline (introductory session) and end of Training Day 3 (about 5 days)

  5. Beck Depression Inventory-II (BDI-II)

    Change in total score (20-item version without the suicidal-thoughts item; range 0 to 60; higher scores indicate more depressive symptoms).

    Time frame: Baseline (introductory session) and end of Training Day 3 (about 5 days)

  6. Event vividness ratings

    Change in vividness ratings (1 to 5) of trained versus untrained events, from Training Day 1 to Training Day 3.

    Time frame: Training Day 1 and Training Day 3

  7. Event affect ratings

    Change in distress (negative events) or joy (positive events) ratings (1 to 5), from Training Day 1 to Training Day 3.

    Time frame: Training Day 1 and Training Day 3

  8. Cued recall

    Percentage of Response Words recalled for trained versus untrained events on Training Day 3.

    Time frame: Training Day 3

Other outcomes

  1. PTSD Checklist for DSM-5 (PCL-5) total score

    20 items rated 0 (Not at all) to 4 (Extremely) for how much each problem bothered the participant, in relation to their worst event, during the past week (adapted from the standard past-month time frame). Total score range 0 to 80; higher scores indicate more severe PTSD symptoms (a worse outcome).

    Time frame: Training Day 3

  2. Cambridge Selective Forgetting Inventory (CSFI)

    32 items rated 0 to 3; total score range 0 to 96. Higher scores indicate a greater self-reported tendency to forget or disengage from unpleasant memories.

    Time frame: Baseline (introductory session)

07

Study locations

1 site
  • VA Palo Alto Medical Center
    Palo Alto, California 94304, United States
08

References and documents

Publications

  • Mamat Z, Anderson MC. Improving mental health by training the suppression of unwanted thoughts. Sci Adv. 2023 Sep 22;9(38):eadh5292. doi: 10.1126/sciadv.adh5292. Epub 2023 Sep 20. PubMed 37729415 ↗

Individual participant data

Plan to share: Undecided — De-identified data may be made available by the investigators on reasonable request, subject to VA data-sharing policy.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Nov 2025 to primary completion in Jul 2026, 8 months.

Of 911 non-industry interventional studies with no phase under Stress Disorders, Post-Traumatic, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 53. This study's 8 months is below that.

Counting every sponsor, half of 937 studies reached it within 35 months; a quarter within 17 and three quarters within 53.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 9, 2026
First posted
Oct 23, 2026
StartActual
Nov 5, 2025
Primary completionActual
Jul 8, 2026
CompletionActual
Jul 8, 2026
Last update
Oct 23, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 23, 2026
Show all 1 update
  1. Oct 23, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07891559
Lead sponsor
Palo Alto Veterans Institute for Research
Collaborators
Stanford University
Responsible party
Peter Bayley (Director of Research, War Related Illness and Injury Study Center, Palo Alto Veterans Institute for Research) — Principal investigator
First posted
Oct 23, 2026
Start date
Nov 5, 2025
Primary completion
Jul 8, 2026
Completion
Jul 8, 2026
Last update
Oct 23, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion